Actigall and Opsumit drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Actigall (ursodiol) and Opsumit (macitentan). Common drug interactions include hypervolaemia among females and mycobacterium abscessus infection among males.
The phase IV clinical study analyzes what interactions people have when they take Actigall and Opsumit. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Actigall?
Actigall has active ingredients of ursodiol. It is often used in gallstones. eHealthMe is studying from 2,162 Actigall users. Check the latest studies of Actigall.
What is Opsumit?
Opsumit has active ingredients of macitentan. eHealthMe is studying from 67,926 Opsumit users. Check the latest studies of Opsumit.
19 people who take Actigall and Opsumit together, and have interactions are studied.

What are the common drug interactions of Actigall and Opsumit, by gender? *:
female:
- Hypervolaemia (abnormally increased volume of blood)
- Portal hypertensive gastropathy (changes in the mucosa of the stomach in patients with portal hypertension;)
- Skin ulcer
- Surgery
- Varices oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach)
- Wound infection pseudomonas
- Ammonia increased
- Compression fracture (fracture due to pressure caused by injury)
- Haemorrhage (bleeding)
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
male:
- Mycobacterium abscessus infection (rapid growing bacterial infection)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
What are the common drug interactions of Actigall and Opsumit, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Back pain
- Blood bilirubin increased
- Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
- Gastrointestinal erosion (gradual destruction of gastrointestinal tract because of the inflamed mucous membrane lining the stomach)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
- Hypervolaemia (abnormally increased volume of blood)
- Portal hypertensive gastropathy (changes in the mucosa of the stomach in patients with portal hypertension;)
- Pulmonary oedema (fluid accumulation in the lungs)
- Skin ulcer
50-59:
- Blindness transient (sudden loss of vision)
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Influenza
- Psoriasis (immune-mediated disease that affects the skin)
- Rectal haemorrhage (bleeding from anus)
60+:
- Death
- Liver disorder (liver diseases)
- Pulmonary oedema (fluid accumulation in the lungs)
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 15 people, 78.95%
- Oedema Peripheral (superficial swelling): 11 people, 57.89%
- Thrombosis (formation of a blood clot inside a blood vessel): 4 people, 21.05%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 21.05%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 5.26%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Actigall and Opsumit?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Actigall and Opsumit:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Actigall:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Opsumit:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Actigall and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Opsumit and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ursodiol and macitentan (the active ingredients of Actigall and Opsumit, respectively), and Actigall and Opsumit (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Baraclude and Sulfamethoxazole - a second ago
- Could Lopressor cause Intestinal Polyp? - 17 seconds ago
- Drug interactions of Zide and Goldenseal - 19 seconds ago
- Could Hytrin cause Blood Urine Present? - 19 seconds ago
- Drug interactions of Viagra and Lovaza - 20 seconds ago
- Could Novolog cause Type 2 Diabetes? - 25 seconds ago
- Could Novolog cause Diabetes Mellitus Non-Insulin-Dependent? - 25 seconds ago
- Drug interactions of Potassium Chloride and Strattera - 31 seconds ago
- Could Basaglar cause Swelling? - 48 seconds ago
- Could Pantoprazole cause Nasal Sinus Cancer? - 54 seconds ago